- Blog
- News & Media
- Issues
- About The Biopharmaceutical Sector
- Access and Affordability
- Adherence
- Appropriate Use Of Medicines
- Counterfeit Drugs
- Disaster Response
- Drug Safety
- Environmental Issues
- Food And Drug Administration
- Importation
- Intellectual Property
- International
- Medical Advances
- Medicare
- Prescription Drug Abuse
- Prescription Drug User Fee Act
- Sales And Marketing
- Value of Medicines
- Research
- About
Cancer Across United States
Related Information
- Read More About Medicines in Development for Cancer
- Media Release: Nearly 1,000 Medicines in Development to Help in the Fight Against Cancer
- 2012 Report: Nearly 1,000 Medicines and Vaccines in Testing Offer Hope in the Fight Against Cancer (PDF)
Source: American Cancer Society, Cancer Facts & Figures 2011.
Notes: These estimates are offered as a rough guide and should be interpreted with caution. State estimates may not sum to US total due to rounding and exclusion of state estimates fewer than 50 cases.
*Rounded to nearest 10. †Estimate is fewer than 50 cases. All sites includes cancer of the females breast, uterine cervix, uterine corpus, colon & rectum, leukemia, lung & bronchus, melanoma of the skin, non-Hodgkin lymphoma, prostate and urinary bladder. Excludes basal and squamous cell skin cancers and in situ carcinomas except urinary bladder.
**Per 100,000, age adjusted to the 2000 US standard population. °Data for 2005 are limited to cases diagnosed from January-June due to the effect of large migrations of populations on this state as a result of Hurricane Katrina in September 2005. ‡This state’s data are not included in the rates for the US overall because its cancer registry did not achieve high-quality data standards for one or more years during 2004-2008 according to the North American Association of Central Cancer Registry (NAACCR) data quality indicators.
